Related references
Note: Only part of the references are listed.Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
Robert T. Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis
Mark J. Taylor et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis
W. David Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Wolbachia Control Stem Cell Behavior and Stimulate Germline Proliferation in Filarial Nematodes
Vincent Foray et al.
DEVELOPMENTAL CELL (2018)
An overview of quinazolines: Pharmacological significance and recent developments
V. Alagarsamy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa
Denis Zofou et al.
PARASITES & VECTORS (2018)
Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model
Sabine Specht et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
Jeff Janes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Reliance of Wolbachia on High Rates of Host Proteolysis Revealed by a Genome-Wide RNAi Screen of Drosophila Cells
Pamela M. White et al.
GENETICS (2017)
Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis
Joseph D. Turner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Reliance of Wolbachia on High Rates of Host Proteolysis Revealed by a Genome-Wide RNAi Screen of Drosophila Cells
Pamela M. White et al.
GENETICS (2017)
Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library
Kelly L. Johnston et al.
SCIENCE ADVANCES (2017)
Wolbachia Modulates Lipid Metabolism in Aedes albopictus Mosquito Cells
Jennifer C. Molloy et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification
Imtiaz Khan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
Kwadwo K. Frempong et al.
CLINICAL INFECTIOUS DISEASES (2016)
Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon
Laura Senyonjo et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Draft genome of Brugia pahangi: high similarity between B-pahangi and B-malayi
Yee-Ling Lau et al.
PARASITES & VECTORS (2015)
Supergroup C Wolbachia, mutualist symbionts of filarial nematodes, have a distinct genome structure
Francesco Comandatore et al.
OPEN BIOLOGY (2015)
What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs
Randee J. Kastner et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control
Joni Lawrence et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Parasitological, Hematological and Biochemical Characteristics of a Model of Hyper- microfilariaemic Loiasis (Loa loa) in the Baboon (Papio anubis)
Samuel Wanji et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The Impact of Host Diet on Wolbachia Titer in Drosophila
Laura R. Serbus et al.
PLOS PATHOGENS (2015)
Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
Martin Walker et al.
CLINICAL INFECTIOUS DISEASES (2015)
The evolution of parasitism in Nematoda
Mark Blaxter et al.
PARASITOLOGY (2015)
Development and Validation of a High-Throughput Anti-Wolbachia Whole-Cell Screen: A Route to Macrofilaricidal Drugs against Onchocerciasis and Lymphatic Filariasis
Rachel H. Clare et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Efficacy of Three-Week Oxytetracycline or Rifampin Monotherapy Compared with a Combination Regimen against the Filarial Nematode Onchocerca ochengi
Germanus S. Bah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms
David H. Molyneux et al.
PARASITES & VECTORS (2014)
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
Alice Halliday et al.
PARASITES & VECTORS (2014)
Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs
Cassan N. Pulaski et al.
PARASITES & VECTORS (2014)
Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review
Bontha V. Babu et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2014)
Phylogenomic analyses uncover origin and spread of the Wolbachia pandemic
Michael Gerth et al.
NATURE COMMUNICATIONS (2014)
Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
Kelly L. Johnston et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
A Comprehensive, Model-Based Review of Vaccine and Repeat Infection Trials for Filariasis
C. Paul Morris et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode Brugia malayi
Ben-Wen Li et al.
BMC GENOMICS (2012)
Corallopyronin A Specifically Targets and Depletes Essential Obligate Wolbachia Endobacteria From Filarial Nematodes In Vivo
Andrea Schiefer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Primer3-new capabilities and interfaces
Andreas Untergasser et al.
NUCLEIC ACIDS RESEARCH (2012)
An inconvenient truth: Global worming and anthelmintic resistance
Ray M. Kaplan et al.
VETERINARY PARASITOLOGY (2012)
A Cell-Based Screen Reveals that the Albendazole Metabolite, Albendazole Sulfone, Targets Wolbachia
Laura R. Serbus et al.
PLOS PATHOGENS (2012)
Utility of DPX2 Cells for Predicting CYP3A Induction-Mediated Drug-Drug Interactions and Associated Structure-Activity Relationships
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Phenotypic Evidence of Emerging Ivermectin Resistance on Onchocerca volvulus
Mike Y. Osei-Atweneboana et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
The endosymbiont Wolbachia increases insulin/IGF-like signalling in Drosophila
Tomoatsu Ikeya et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis
Achim Hoerauf
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis:: a randomized placebo-controlled study (vol 197, pg 295, 2008)
Achim Hoerauf et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2008)
Enhancements and modifications of primer design program Primer3
Triinu Koressaar et al.
BIOINFORMATICS (2007)
Rickettsia as obligate and mycetomic bacteria
M. Alejandra Perotti et al.
FASEB JOURNAL (2006)
A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection
JD Turner et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antibiotic chemotherapy of onchocerciasis:: In a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species)
J Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti:: a double-blind, randomised placebo-control led trial
MJ Taylor et al.
LANCET (2005)
The Wolbachia genome of Brugia malayi:: Endosymbiont evolution within a human pathogenic nematode
J Foster et al.
PLOS BIOLOGY (2005)
Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR
F Fenollar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood
HF Cross et al.
LANCET (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
In vitro activity of antimicrobial agents against the endosymbiont Wolbachia pipientis
PG Hermans et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control
MJ Taylor
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Longevity and ageing in parasitic and free-living nematodes
D Gems
BIOGERONTOLOGY (2000)
Share Paper
